//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Lecouvet F.E. et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. 2012;62:68. https://www.ncbi.nlm.nih.gov/pubmed/22366187.

Welty C.J. et al. Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol. 2014;24:288. https://www.ncbi.nlm.nih.gov/pubmed/24614347.

Loeb S. et al. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol. 2015;67:619. https://www.ncbi.nlm.nih.gov/pubmed/25457014.

Hamdy F.C. et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med. 2016;375:1415. https://www.ncbi.nlm.nih.gov/pubmed/27626136.

Chodak G.W. et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242. https://www.ncbi.nlm.nih.gov/pubmed/8272085.

Lu-Yao G.L. et al. Outcomes of localized prostate cancer following conservative management. Jama. 2009;302:1202. https://www.ncbi.nlm.nih.gov/pubmed/19755699.

Steineck G. et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790. https://www.ncbi.nlm.nih.gov/pubmed/12226149.

Eastham J.A. et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170:2292. https://www.ncbi.nlm.nih.gov/pubmed/14634399.

Vickers A.J. et al. The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. Lancet Oncol. 2009;10:475. https://www.ncbi.nlm.nih.gov/pubmed/19342300 114 PROSTATE CANCER - UPDATE MARCH 2017.

Trinh Q.D. et al. A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol. 2013;64:786. https://www.ncbi.nlm.nih.gov/pubmed/23664423.

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Kattan M.W. et al. Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. Clin Prostate Cancer. 2003;15040880(1):221. https://www.ncbi.nlm.nih.gov/pubmed/15040880.

Briganti A. et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012;61:480. https://www.ncbi.nlm.nih.gov/pubmed/22078338.

Rider J.R. et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol. 2013;63:88. https://www.ncbi.nlm.nih.gov/pubmed/22902040.

Donohue J.F. et al. Poorly differentiated prostate cancer treated with radical prostatectomy: longterm outcome and incidence of pathological downgrading. J Urol. 2006;176:991. https://www.ncbi.nlm.nih.gov/pubmed/16890678.

Yossepowitch O. et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol. 2008;53:950.

Gerber G.S. et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol. 1997;32:385. https://www.ncbi.nlm.nih.gov/pubmed/9412793.

Mattei A. et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol. 2008;53:118. https://www.ncbi.nlm.nih.gov/pubmed/17709171.

Briganti A. et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol. 2009;55:261. https://www.ncbi.nlm.nih.gov/pubmed/18838212.

Engel J. et al. Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol. 2010;57:754. https://www.ncbi.nlm.nih.gov/pubmed/20106588.